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Abstract
Objectives: Current clinical studies report the results of laparoscopic resection of hepatocellular carci-
noma (HCC) obtained in small cohorts of patients. Because France was involved in the very early
development of laparoscopic surgery, the present study was conducted in order to report the results of
a large, multicentre experience.
Methods: A total of 351 patients underwent laparoscopic liver resection for HCC during the period from
1998 to 2010 in nine French tertiary centres. Patient characteristics, postoperative mortality and morbid-
ity, and longterm survival were retrospectively reviewed.
Results: Overall, 85% of the study patients had underlying liver disease. Types of resection included
wedge resection (41%), left lateral sectionectomy (27%), segmentectomy (24%), and major hepatectomy
(11%). Median operative time was 180 min. Conversion to laparotomy occurred in 13% of surgeries and
intraoperative blood transfusion was necessary in 5% of patients. The overall morbidity rate was 22%.
The 30-day postoperative mortality rate was 2%. Negative resection (R0) margins were achieved in 92%
of patients. Rates of overall and progression-free survival at 1, 3 and 5 years were 90.3%, 70.1% and
65.9%, and 85.2%, 55.9% and 40.4%, respectively.
Conclusions: This multicentre, large-cohort study confirms that laparoscopic liver resection for HCC is
a safe and efficient approach to treatment and can be proposed as a first-line treatment in patients with
resectable HCC.
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Introduction
Hepatocellular carcinoma (HCC), a cancer of frequent and world-
wide occurrence, is most often associated with liver disease,
mainly chronic hepatitis and cirrhosis.1 In recent years, liver trans-
plantation has appeared to be successful in the treatment of both
cancer and underlying liver disease.2 The limited number of liver
grafts available does not permit transplantation in all patients
with early HCC. In patients with normal liver function, partial
hepatic resection is still indicated as the primary treatment and
leads to survival rates within the same range as those of patients
who undergo liver transplantation on an intention-to-treat basis.3
Moreover, partial resection allows complete information about
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the pathology and prognostic characteristics of the resected
tumour to be obtained, and thus facilitates the selection of the best
candidates for further liver transplantation.4 However, conven-
tional partial resection still carries a high risk for complications.
Laparoscopy has rapidly come to be recognized as a surgical
technique that can decrease morbidity and shorten the hospital
length of stay, as well as allowing other benefits. The results of
randomized studies have led both surgeons and patients to regard
laparoscopy as appropriate in the surgical treatment of various
digestive diseases, including colon cancer.5,6 However, liver sur-
geons have been reluctant to use laparoscopy for several reasons,
including the technical difficulties involved in liver exploration
and mobilization, as well as in vascular control and parenchyma
transection.7 These technical challenges, which are even more haz-
ardous in patients with cirrhosis, may lead to an increased risk for
haemorrhage and compromise the improvements in oncological
results that liver surgeons have achieved in open liver surgery in
recent years. For these reasons, the diffusion of laparoscopic liver
surgery remains limited and thus most articles report the results of
fairly small cohorts of patients in non-controlled studies. In the
absence of randomized controlled studies, robust clinical data are
needed to define the role of laparoscopy in the resection of HCC.
Thus, this study was designed to review the results of such laparo-
scopic liver resections in HCC at a nationwide level in France, a
Western country in which laparoscopy gained early popularity
among surgeons.
Materials and methods
Study population
Prospective data for patients who underwent laparoscopic resec-
tion of HCC during the period from 1998 to 2010 were retrospec-
tively retrieved from the databases of nine French tertiary centres.
These centres were experienced in both open and laparoscopic
liver surgery. Preoperative general evaluation relied on the
patient’s American Society of Anesthesiologists (ASA) score, age,
severity of underlying liver disease assessed by the Model for
End-stage Liver Disease (MELD) score, Child–Pugh class and
presence of significant portal hypertension with oesophageal
varices (grade II or greater). The decision to undertake surgical
resection was based on expert opinion delivered at a multidisci-
plinary meeting. Selection criteria for laparoscopic resection were
determined by the surgeon or local surgical team on the basis of
tumour size and location [assessed by computed tomography
(CT) and/or magnetic resonance imaging (MRI)], according to
which suitability for laparoscopic resection was evaluated, and on
a preoperative general evaluation of the patient. Patients present-
ing with decompensated cirrhosis (Child–Pugh classes B and C)
or an ASA score of >3 were deemed to be unsuitable for surgical
resection, including by laparoscopy.
Surgical technique
The surgical techniques for laparoscopic liver resection have been
described previously.7–9 All liver resections were intended to be
totally laparoscopic and were performed according to the proce-
dures described and the surgeon’s usual practice. The patient was
placed in a supine position with the legs apart, except in posterior
liver (segments VI and VII) resections, in which left lateral decu-
bitus positioning with an elevated right arm was chosen. Pneu-
moperitoneum was created by carbon dioxide insufflation at a
pressure of 12–14 mmHg, and a 0-degree or 30-degree laparo-
scope was used. Parenchymal transection was performed with an
ultrasonic dissector, or harmonic scalpel, in accordance with
the surgeon’s usual practice. Small vessels were controlled with
bipolar coagulation or a harmonic scalpel. Larger vessels were
clipped or electively stapled. The use of portal triad clamping was
not systematic and depended upon the surgeon’s habits and the
amount of bleeding. The specimen was extracted through a
suprapubic incision whenever possible in a dedicated laparoscopy
bag. All resected specimens were sent to the pathology department
for analysis. All surgeons were experienced in hepatic and laparo-
scopic surgery. Types of resection were defined according to the
Brisbane 2000 classification.10 Minor resections involved two or
fewer segments; major resections removed at least three segments.
Resections of less than one segment (according to Couinaud’s
classification) were non-anatomical or wedge resections.
Postoperative management and follow-up
Postoperatively, patients were admitted to the intensive care unit
only after major hepatic resection. After minor resections, patients
were admitted to the surgical ward. Postoperative monitoring
included liver biochemical tests on postoperative days 1, 3 and 5.
Ultrasound and/or CT scans were indicated only in the event of
complications. The occurrence of medical or surgery-related
complications was closely monitored, as in open liver surgery.
Morbidity was stratified by severity according to the Clavien–
Dindo system of classification. Surgical complications included
biliary leak, intra-abdominal collection, and parietal complica-
tions. Mid- and longterm follow-up included clinical, biological
and radiological assessment at 1 month after surgery and subse-
quently every 6 months in all centres.
Evaluation criteria
Intraoperative evaluation criteria were operation duration, trans-
fusion rate, need for and duration of a Pringle manoeuvre or
portal triad clamping, and incidence of conversion to laparotomy.
Postoperative parameters studied included: pathological margins;
postoperative medical and surgical complications; 30- and 90-day
mortality, and duration of hospital stay. Longterm survival and
recurrence rates were estimated at 1, 3 and 5 years.
Data on clinicopathological factors, such as age, sex, ASA grade,
preoperative hepatic function, underlying liver disease and its
cause, number and size of tumours, fulfilling of the Milan Criteria,
vascular invasion, presence of satellite nodules, and pathological
margins, were collected.
An additional analysis referred to survival outcomes in a sub-
group of patients with a good prognosis defined by Child–Pugh
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class A status, absence of portal hypertension, and the presence of
a single well or moderately differentiated tumour without satellite
nodule or vascular invasion and of 5 cm in diameter.
Margin status was assessed by the pathologist as follows: R0
resection was defined as a complete resection with no microscopic
residual tumour; R1 resection was defined as a complete resection
with no macroscopically visible tumour as defined by the surgeon,
but with microscopically positive margins, and R2 resection was
defined as a partial resection in which macroscopically visible
tumour was retained.
Statistical analysis
Clinical data were expressed as the median (range) or frequency as
appropriate.
Overall survival (OS) was computed from the date of opera-
tion. Progression-free survival (PFS) was the time to recurrence or
death, whichever came first.
Survival curves were estimated using the Kaplan–Meier method
and compared using log-rank tests. To detect factors associated
with survival in patients who underwent laparoscopic resection of
HCC, univariate analysis was used to verify the relationship
between survival and the following variables: a-fetoprotein (AFP)
level at the time of HCC resection (<200 ng/ml or >200 ng/ml);
preoperative transarterial chemoembolization (performed or not
performed); extent of hepatectomy (major or minor); pedicle
clamping (required or not required); intraoperative blood trans-
fusion (required or not required); postoperative complication
(present or absent); cirrhosis (present or absent); fibrosis of F3
(present or absent); number of HCC nodules (single or multiple);
tumour capsule (present or absent); satellite nodules (present or
absent); differentiation of HCC (poor or good/moderate differ-
entiation); vascular invasion (present or absent), and a histologi-
cally tumour-free margin (present or absent). All variables
associated with survival that resulted in a P-value of <0.15 in
univariate proportional hazards models were subsequently
entered into a Cox multivariate regression model with backward
elimination. Missing covariate values were considered to be
missing at random and data for patients for whom such informa-
tion was missing were not included in the regression. P-values of
<0.05 were considered to indicate statistical significance.
Results
Patient characteristics
The clinicopathological characteristics of the 351 patients with
HCC are given in Table 1. Their median age was 63 years; 260
(74%) patients were male. Preoperative underlying liver disease
was known in 268 (76%) patients and was predominantly related
to hepatitis C virus infection in 33% (113/345) and alcohol abuse
Table 1 Clinicopathological characteristics of patients submitted to laparoscopic liver resection for hepatocellular carcinoma
Characteristic Patients assessed, n Value
Age, years, median (range) 351 63 (30–90)
Sex, male/female, n (%) 351 260 (74%)/91 (26%)
Body mass index, kg/m2, median (range) 194 26.4 (17.0–45.1)
a-fetoprotein, ng/ml, median (range) 151 67 (0–65 000)
a-fetoprotein level 200 ng/ml, n (%) 259 43 (17%)
American Society of Anesthesiologists (ASA) class, n (%) 289
1 47 (16%)
2 151 (52%)
3 90 (31%)
4 1 (0.003%)
Child–Pugh class, n (%) 284
A 275 (97%)
B 8 (3%)
C 1 (0.003%)
Known underlying liver disease, n (%) 351 268 (76%)
Hepatitis B virus 345 46 (13%)
Hepatitis C virus 345 113 (33%)
Alcohol 323 105 (33%)
Non-alcoholic steatohepatitis 283 20 (7%)
Other 283 60 (21%)
Preoperative transarterial chemoembolization, n (%) 284 21 (7%)
Preoperative portal vein embolization, n (%) 283 20 (7%)
Preoperative tumour biopsy, n (%) 283 47 (17%)
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in 30% (105/323) of patients (Fig. 1). In this series, 97% (275/284)
of patients were of Child–Pugh class A. Preoperative portal hyper-
tension was found in 70 (20%) patients, assessed by oesophageal
varices [grade I (n = 45), grade II (n = 19), grade III (n = 6)].
Endoscopic ligation was performed before resection.
Figure 2 shows annual incidences of laparoscopic resection of
HCC and indicates a steady increase over the study period to
30–40 procedures per year in the late 2000s.
Surgical procedures
Types of resection and intraoperative data are given in Table 2.
Conversion to laparotomy was necessary in 13% of patients. The
main cause for conversion was bleeding, but the reason for con-
version was not recorded in 60% of conversions. The hand-
assisted technique was not used for conversion.
Postoperative outcomes
Mortality rates at 30 days and 90 days were 2.0% and 2.8%, respec-
tively (Table 3). Overall morbidity was 22.8% (80 patients) with
an overall major morbidity (Clavien grades of 3 and 4) rate of
4.8% (17 patients). The most frequent complications were infec-
tions (18 patients) and ascites (16 patients). Bile leak occurred in
seven patients. Postoperative red blood cell transfusions were
given in 12 patients.
Histological features are given in Table 4. Cirrhosis or severe
fibrosis was present in 302 (86%) patients. Hepatocellular carci-
noma presented as a single nodule in 86% of cases. Microvascular
invasion was present in 34% of cases and tumour-free margins
were obtained in 92% of patients.
Survival
Median follow-up was 21 months (range: 1–134 months). Rates of
OS and PFS at 5 years were 65.6% and 36.8%, respectively (Fig. 3).
The subgroup of HCC patients with a better prognosis included
63 patients in whom median follow-up amounted to 32 months
(range: 1–130 months). In this group, 5-year OS and PFS rates
were 90.2% and 47.1%, respectively (Fig. 4).
Predictors of outcome
In univariate analysis, the presence of an AFP serum level of
>200 ng/ml [hazard ratio (HR) = 2.6, P = 0.001], cirrhosis (HR =
3.2, P = 0.002), multiple tumour nodules (HR = 3.0, P < 0.0001),
satellite nodules (HR = 2.2, P = 0.001), poorly differentiated
tumour (HR = 3.0, P = 0.0003) and vascular invasion (P = 0.0001)
were associated with worse OS after laparoscopic resection of
HCC. In the multivariate analysis, AFP of >200 ng/ml, cirrhosis
and vascular invasion remained independently associated with
worse OS after laparoscopic resection of HCC (Table 5).
With respect to PFS, the presence of cirrhosis (P = 0.0008),
multiple tumour nodules (P = 0.003), satellite nodules (P =
0.0003), poor tumour differentiation (P = 0.002) and vascular
invasion (P = 0.001) were associated with worse tumour-free sur-
vival after laparoscopic resection of HCC. In the multivariate
analysis, cirrhosis, poor differentiation and vascular invasion
remained independently associated with an increased risk for
recurrence (Table 6).
Discussion
This study provides evidence in support of the claim that laparo-
scopic resection of HCC is a safe and reliable procedure that is
associated with prolonged survival in patients with HCC and in
the majority of patients with chronic liver disease. The relevance
of this study is derived from its large sample of patients, which
reflects a nationwide collection of experience at nine tertiary
hepatopancreatobiliary surgical centres in a single country. The
present study found an OS rate of 65.6%. This result was achieved
despite the fact that laparoscopic resection of HCC is a signifi-
cantly challenging procedure in the presence of underlying liver
disease. Indeed, severe fibrosis or cirrhosis, present in 85% of
patients in the present series, increase the risk for haemorrhage
and subsequent transfusion during liver resection.11 Moreover, the
technical difficulties of the laparoscopic approach are increased by
the characteristics of cirrhotic livers, such as dysmorphia, hyper-
vascularized ligaments, and a hard parenchyma that is difficult to
cut and to explore by ultrasound.
An 5-year OS rate of 65.6%, postoperative 30- and 90-day mor-
tality rates of 2.0% and 2.8%, respectively, and an intraoperative
transfusion rate of 5% fulfil modern standards for HCC resection
in patients with cirrhosis as defined in the 2012 clinical practice
guidelines recommended by the European Association for the
Study of the Liver (EASL) and the European Organization for
Research and Treatment of Cancer (EORTC), which include
expected 5-year survival rates of 60%, perioperative mortality of
2–3% and blood transfusion requirements in <10% of patients.12
These results are within the range of those obtained by open
resection and reported in recent series,3,13 in which 5-year survival
Figure 1 Aetiologies of underlying liver disease in patients submitted
to laparoscopic liver resection for hepatocellular carcinoma. HBV,
hepatitis B virus; HCV, hepatitis C virus; NASH, non-alcoholic
steatohepatitis
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rates range from 53% to 72%. Given that optimal partial resection
can compete with liver transplantation, a pragmatic way to select
patients and compare results would be to analyse results in
patients with HCC that fall within the Milan Criteria.3
The overall morbidity rate of 22.8% identified in the present
study was quite low and compares favourably with those observed
after open surgery, especially in the setting of cirrhosis. Biliary
fistula, a concern in laparoscopic liver resection, occurred infre-
quently at an incidence of 2%. With respect to specific morbidity,
the incidence of postoperative ascites was as low as 5%. This
finding has been underlined in previous studies and in meta-
analyses of comparative studies, which indicate that laparoscopy is
associated with a significantly lower incidence of postoperative
cirrhosis decompensation than is open surgery.14–17
An interesting finding refers to that of the low transfusion rate
of 5%. Allogeneic blood transfusion has been shown to be an
Figure 2 Annual incidences of laparoscopic liver resection for hepatocellular carcinoma in nine French tertiary centres during 1998–2010
Table 2 Operative data in 351 patients submitted to laparoscopic
liver resection for hepatocellular carcinoma
Operative data Value
Type of laparoscopic main liver resection, n (%)
Major hepatectomy 36 (10%)
Right hepatectomy 20 (6%)
Left hepatectomy 14 (4%)
Central hepatectomy 2 (0.5%)
Left lateral sectionectomy, n (%) 92 (26%)
Segmentectomy, n (%) 83 (24%)
Wedge resection, n (%) 140 (40%)
Per-procedure transfusion requirement, n (%) 17 (5%)
Conversion to laparotomy, n 45 (13%)
For dissection difficulties 2
For biliary leak 2
For haemorrhage 14
Reason not specified 27
Pedicle clamping, n (%) 85 (24%)
Duration of clamping, min, median (range) 36 (3–117)
Operating time, min, median (range) 180 (15–655)
Tumour-free margin, mm, median (range) 10 (0–78)
Table 3 Outcomes in 351 patients submitted to laparoscopic liver
resection for hepatocellular carcinoma
Postoperative data Value
Length of hospital stay, days, median (range) 7 (1–90)
30-day mortality, n (%) 7 (2%)
90-day mortality, n (%) 10 (3%)
Overall morbidity, n (%) 80 (23%)
Infections 18 (5%)
Biliary leak 7 (2%)
Ascites 16 (5%)
Hepatic encephalopathy 5 (1%)
Intra-abdominal fluid collection 6 (2%)
Portal venous thrombosis 3 (1%)
Postoperative blood transfusion requirement, n (%) 12 (3%)
Clavien–Dindo classification, n (%)
I 35 (10%)
II 21 (6%)
IIIa 3 (1%)
IIIb 8 (2%)
IVa 5 (1%)
IVb 1 (0.3%)
V 6 (2%)
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independent risk factor for the recurrence of colorectal cancer,18,19
HCC20 and cholangiocarcinoma,21 amongst other diseases.
Moreover, both intraoperative blood loss and allogeneic blood
product transfusions have a negative impact on postoperative
outcome, recurrence and survival in patients with HCC.11 The
immunosuppressive effect of blood transfusion won early recog-
nition in the setting of kidney transplantation, in which a donor-
specific blood transfusion to the recipient was found to decrease
the incidence of acute rejection. The non-specific immunosup-
pression induced by blood transfusion may explain the increased
postoperative morbidity and recurrence of cancer observed after
liver resection for HCC. Laparoscopy is usually associated with
decreases in blood loss and transfusion requirements compared
with open procedures in various types of surgery, such as colec-
tomy,5 pancreaticoduodenectomy22 and liver resection for HCC.23
The usual explanation for the decrease in blood loss observed
during laparoscopy is the presence of pneumoperitoneum,24 as
well as the fact that the magnified vision afforded by laparoscopy
allows for an optimal parenchymal transection. Most comparative
studies and meta-analyses have found significant decreases in
blood loss and requirements for blood transfusions in laparoscopy
subgroups among patients undergoing liver resection for
HCC.23,25,26 This key point may represent the major advantage of
laparoscopy in liver surgery.
Surgical resection is the first-line treatment in patients with
early HCC, preserved liver function, and without portal hyperten-
sion.12 This recommendation addresses the conventional
approach through laparotomy; however, the indications for, asso-
ciated morbidity and oncological results of laparoscopic resection
Table 4 Pathological features in 351 patients submitted to laparo-
scopic liver resection for hepatocellular carcinoma (HCC)
Postoperative data Value
Histological cirrhosis, n (%) 247 (70%)
Histological fibrosis F2, F3, n (%) 55 (16%)
Maximum tumour size, mm, median (range) 35 (5–170)
Single HCC, n (%) 302 (86%)
Multiple HCC, n (%) 49 (14%)
Bilobar HCC, n (%) 24 (7%)
Encapsulated HCC, n (%) 162 (46%)
Satellite nodules, n (%) 81 (23%)
Well or moderately differentiated HCC, n (%) 319 (91%)
Poorly differentiated HCC, n (%) 32 (9%)
Vascular invasion, n (%) 119 (34%)
Tumour-free margin, n (%) 323 (92%)
Margin, mm, median (range) 10 (0–78)
10
0
80
60
40
20
0
P
ro
po
rt
io
n 
of
 p
at
ie
nt
s
2 3 4 510
Time from surgery, years
Number at risk
OS
PFS
341
341
220
182
152
107
95
63
69
42
45
24
Overall survival
Progression-free
survival
Figure 3 Overall survival (OS) and progression-free survival (PFS) in
351 patients submitted to laparoscopic liver resection for hepato-
cellular carcinoma during 1998–2010
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Figure 4 Overall survival (OS) and progression-free survival (PFS) in
63 patients with good prognoses submitted to laparoscopic liver
resection for hepatocellular carcinoma during 1998–2010
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of HCC have not been well defined, mainly because randomized
controlled trials are lacking. Only rather small cohorts,27–29 with or
without retrospective comparisons with data for open surgery
patients,14–17 have been published, and have led to three meta-
analyses.23,25,26 Large-scale retrospective research such as that con-
ducted in the present study may prove more useful than small
series in providing clinical data to help clarify potential indica-
tions for the laparoscopic approach.
Anatomical resections are recommended for HCC,9 but may be
more difficult to perform through laparoscopy. In the present
study, however, 60% of patients underwent anatomical resection,
which, in the setting of cirrhosis, represents a high proportion
compared with those in other series, even in open surgery, in
which rates of anatomical resection range from 22% to 74%.13,30
The conversion rate of 13% was higher than those observed in
other types of laparoscopic surgery, such as colectomy,5 but has
significantly decreased since the first reports of HCC resection, in
which it often reached 20%.28 An analysis of causes of conver-
sion is not possible in the present series because the reasons for
conversion were not specified in over half of the patients.
However, difficult exposure and haemorrhage are the main causes
of conversion reported in the literature.31
Table 5 Univariate and multivariate analyses of factors associated with overall survival in 351 patients submitted to laparoscopic liver
resection for hepatocellular carcinoma
Predictor of overall survival n (%) Univariate analysis Multivariate analysisa
HR (95% CI) P-value HR (95% CI) P-value
AFP 200 ng/ml versus AFP <200 ng/ml 60 (17%) 2.56 (1.46–4.48) 0.001 2.4 (1.3–4.2) 0.003
Preoperative transarterial chemoembolization 25 (7%) 2.20 (0.94–5.19) 0.07
Major hepatectomy 38 (11%) 1.01 (0.46–2.23) 0.98
Pedicle clamping 85 (24%) 0.95 (0.58–1.56) 0.84
Blood transfusion requirement 28 (8%) 1.68 (0.72–3.88) 0.23
Cirrhosis 247 (70%) 3.2 (1.6–6.7) 0.002 2.9 (1.2–6.7) 0.02
Single versus multiple HCC 302 (86%) 3.0 (1.74–5.12) <0.0001
Encapsulated HCC 162 (46%) 1.26 (0.79–2.01) 0.33
Satellite nodules 81 (23%) 2.21 (1.36–3.59) 0.001
Poor versus good/moderate differentiation 32 (9%) 3.0 (1.6–5.5) 0.0003
Vascular invasion 99 (34%) 2.5 (1.59–4.0) <0.0001 2.65 (1.6–4.4) 0.0002
Tumour-free versus not tumour-free margin 323 (92%) 0.64 (0.27–1.49) 0.3
aCox's regression model multivariate analysis included all variables with a P-value of <0.15 in univariate analysis.
HR, hazard ratio; 95% CI, 95% confidence interval; AFP, a-fetoprotein.
Table 6 Univariate and multivariate analyses of factors associated with progression-free survival in 351 patients submitted to laparoscopic
liver resection for hepatocellular carcinoma (HCC)
Predictor of overall survival n (%) Univariate analysis Multivariate analysisa
HR (95% CI) P-value HR (95% CI) P-value
AFP 200 ng/ml versus AFP <200 ng/ml 60 (17%) 1.6 (0.97–2.51) 0.07
Preoperative transarterial chemoembolization 25 (7%) 1.19 (0.58–2.45) 0.64
Major hepatectomy 38 (11%) 0.85 (0.49–1.49) 0.57
Pedicle clamping 85 (24%) 1.15 (0.8–1.66) 0.45
Blood transfusion requirement 28 (8%) 1.55 (0.86–2.8) 0.15
Cirrhosis 247 (70%) 2.03 (1.34–3.08) 0.0008 2.3 (1.3–3.8) 0.002
Single versus multiple HCC 302 (86%) 2 (1.28–3.12) 0.003
Encapsulated HCC 162 (46%) 1.3 (0.91–1.85) 0.15
Satellite nodules 81 (23%) 1.98 (1.36–2.86) 0.0003
Poor versus good/moderate differentiation 32 (9%) 2.2 (1.33–3.6) 0.0024 1.8 (1.1–2.9) 0.004
Vascular invasion 119 (34%) 1.75 (1.23–2.48) 0.0017 2.1 (1.5–3.1) <0.0001
Tumour-free versus not tumour-free margin 323 (92%) 1.17 (0.54–2.51) 0.69
aCox's regression model multivariate analysis included all variables with a P-value of <0.15 in univariate analysis.
HR, hazard ratio; 95% CI, 95% confidence interval; AFP, a-fetoprotein.
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Oncological outcomes identified in the present study, in terms
of survival and recurrence rates, were comparable with those
reported after open surgery.23 However, it is difficult to analyse the
R0 rate in the present study because definitions of R0 resection
were not clearly stated and were subject to variation among
centres. The multivariate analysis identified factors that are known
to influence OS and PFS in patients with HCC, especially tumour-
related factors such as poor differentiation, and the presence of
satellite nodules and microvascular invasion, as well as the pres-
ence of underlying cirrhosis. These factors were significantly and
independently associated with an increased risk for recurrence.
The risk imposed by tumour-related factors such as vascular inva-
sion underlines the impact of anatomic resection on prognosis.
The good results obtained in the subgroup of HCC patients in
whom tumour characteristics were considered to indicate a better
prognosis support the claim that partial liver resection can
compete with liver transplantation in this group of patients and
help to identify those patients who will eventually need a liver
transplant.4,30 Here, laparoscopy may provide another advantage.
Laurent et al. found that during liver transplantation, the duration
of hepatectomy and volume of blood loss, as well as that of blood
transfusion, were significantly decreased in patients who had
undergone previous laparoscopic resection of HCC compared
with those who had undergone open surgery.32 Laparoscopy is
well known for making subsequent surgical procedures easier
because the formation of intra-abdominal adhesions is reduced
after laparoscopic surgery compared with after open surgery.
In view of the present results, which reflect findings collected
over a long period in France, laparoscopic liver resection for HCC
occurring on a background of chronic liver disease appears to
represent a viable alternative to open surgery. Moreover, laparo-
scopic resection should be considered as a curative treatment of
HCC in patients with preserved liver function, not simply as a
bridge to liver transplantation, especially in patients with tumours
characterized as affording a better prognosis. Laparoscopic liver
resection for HCC may represent the missing link in the treatment
of HCC because it provides both the oncological advantages of
surgical resection and low morbidity rates that are closer to those
of ablative techniques than of open surgery.
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